PSNL

Personalis (PSNL)

Personalis Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:PSNL

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/22	22:05	Business Wire	Personalis Announces Podium Presentations and Abstracts Accepted at ASCO 2024	NASDAQ:PSNL	Personalis Inc
2024/05/22	10:14	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PSNL	Personalis Inc
2024/05/22	10:11	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PSNL	Personalis Inc
2024/05/22	05:12	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PSNL	Personalis Inc
2024/05/18	05:05	Business Wire	Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:PSNL	Personalis Inc
2024/05/09	05:01	Business Wire	Personalis Reports First Quarter 2024 Financial Results	NASDAQ:PSNL	Personalis Inc
2024/05/09	05:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PSNL	Personalis Inc
2024/04/25	05:01	Business Wire	Personalis to Announce First Quarter 2024 Financial Results	NASDAQ:PSNL	Personalis Inc
2024/03/29	05:01	Business Wire	Personalis to Present at the 23rd Annual Needham Virtual Healthcare Conference	NASDAQ:PSNL	Personalis Inc
2024/03/28	22:00	Business Wire	Data Showcasing NeXT Personal MRD Test to be Presented at the 2024 American Association for Cancer Research (AACR) Annual Meeting	NASDAQ:PSNL	Personalis Inc
2024/03/26	22:00	Business Wire	Personalis Announces Publication Validating NeXT Personal® Test for Ultra-sensitive MRD Detection and Cancer Treatment Response Monitoring	NASDAQ:PSNL	Personalis Inc
2024/03/20	05:43	Business Wire	Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:PSNL	Personalis Inc
2024/02/29	06:01	Business Wire	Personalis Reports Fourth Quarter and Full Year 2023 Financial Results	NASDAQ:PSNL	Personalis Inc
2024/02/29	06:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PSNL	Personalis Inc
2024/02/15	06:01	Business Wire	Personalis to Announce Fourth Quarter and Full Year 2023 Financial Results	NASDAQ:PSNL	Personalis Inc
2024/02/01	06:30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PSNL	Personalis Inc
2024/02/01	06:01	Business Wire	Personalis to Participate at Upcoming Investor Conferences	NASDAQ:PSNL	Personalis Inc
2024/01/30	23:00	Business Wire	Personalis and ClearNote Health Announce Partnership to Advance Epigenomic Technology	NASDAQ:PSNL	Personalis Inc
2024/01/30	06:00	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:PSNL	Personalis Inc
2024/01/18	06:15	Business Wire	Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:PSNL	Personalis Inc
2024/01/16	23:05	Business Wire	Personalis Announces Medicare Coverage for NeXT Dx(R) Comprehensive Genomic Tumor Profiling Assay	NASDAQ:PSNL	Personalis Inc
2024/01/10	14:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:PSNL	Personalis Inc
2024/01/09	14:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:PSNL	Personalis Inc
2024/01/05	23:09	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PSNL	Personalis Inc
2024/01/05	23:05	Business Wire	Personalis Reports Preliminary Fourth Quarter and Full Year 2023 Revenue and Cash Balance	NASDAQ:PSNL	Personalis Inc
2023/12/22	07:15	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:PSNL	Personalis Inc
2023/12/22	07:12	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:PSNL	Personalis Inc
2023/12/20	08:09	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PSNL	Personalis Inc
2023/12/20	08:02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PSNL	Personalis Inc
2023/12/06	06:07	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:PSNL	Personalis Inc